Biogen’s Q2 Earnings

Name: Biogen’s Q2 Earnings
Uploaded: 2021-09-01T14:40:57+00:00
Duration: 27 s
Channel: Benzinga
Description: Fueled by their Alzheimer's drug, Biogen’s ($BIIB@US) earnings report beat expectations as they reported $2.78 billion in revenue, beating the $2.61 billion projected by analysts. Their controversial Alzheimer's drug saw $2 million in revenue after only being approved a few weeks ago. Shares of Biogen were down 0.59% today at press time.

Benzinga

Fueled by their Alzheimer's drug, Biogen’s ($BIIB@US) earnings report beat expectations as they reported $2.78 billion in revenue, beating the $2.61 billion projected by analysts. Their controversial Alzheimer's drug saw $2 million in revenue after only being approved a few weeks ago. Shares of Biogen were down 0.59% today at press time.

Featured channels